series-b
Stage
About
Lykospbc is developing investigational psychedelic-based therapies, including MDMA-assisted treatment, focused on mental health conditions such as post-traumatic stress disorder (PTSD). The company runs clinical trials and has received FDA authorization for expanded access programs.
Explore Lykospbc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.